SCHEMBL8089240

SCHEMBL8089240

N=C(N)c1cccc(Cc2c[nH]cn2)c1O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HMGB1 P09429 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mivazerol SCHEMBL593708 0.86 PARP1 (0.39) HMGB1
Mivazerol SCHEMBL8097939 0.86 PARP1 (0.39) HMGB1
SCHEMBL9132003 0.85
Mivazerol SCHEMBL8865135 0.85 PARP1 (0.38) HMGB1
SCHEMBL8095569 0.84
SCHEMBL8088784 0.84 LMNA (0.31) HMGB1
SCHEMBL8088780 0.84
SCHEMBL8095573 0.83
SCHEMBL9127794 0.83
SCHEMBL9647479 0.82 P2RX7 (0.39) HMGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0626372-B1 2-hydroxy-3-[1-(1H-imidazol-4-yl)alkyl]benzenecarboximid-amides for the treatment of glaucoma UCB SA (BE) 2000-12-20 EP claimed
US-5385927-A Hydroxy-3-[1-(1H-imidazol-4-yl)alkyl]-benzenecarboximidamides and their use in treating glaucoma U C B, S.A. (BE) 1995-01-31 US claimed
EP-0626372-A1 2-hydroxy-3- 1-(1H-imidazol-4-yl)alkyl benzenecarboximid-amides for the treatment of glaucoma U C B, S.A. (BE) 1994-11-30 EP claimed
JP-7070082-A None JP disclosed
EP-0626372-B1 2-hydroxy-3-[1-(1H-imidazol-4-yl)alkyl]benzenecarboximid-amides for the treatment of glaucoma UCB SA (BE) 2000-12-20 EP disclosed
JP-H0770082-A 2-HYDROXY-3-(1-(1H-IMIDAZOL-4-YL) ALKYL)BENZENECARBOXIMIDAMIDE UCB SA 1995-03-14 JP disclosed
US-5385927-A Hydroxy-3-[1-(1H-imidazol-4-yl)alkyl]-benzenecarboximidamides and their use in treating glaucoma U C B, S.A. (BE) 1995-01-31 US disclosed
EP-0626372-A1 2-hydroxy-3- 1-(1H-imidazol-4-yl)alkyl benzenecarboximid-amides for the treatment of glaucoma U C B, S.A. (BE) 1994-11-30 EP disclosed